X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
https://www.prnewswire.com/news-releases/lupin-signs-promotional-agreement-with-exeltis-on-solosec-secnidazole-expanding-access-for-adult-women-suffering-with-bacterial-vaginosis-and-adults-with-trichomoniasis-301469860.html
https://www.expresspharma.in/lupin-gets-usfda-approval-of-snda-for-solosec-secnidazole-to-treat-trichomoniasis/
https://www.prnewswire.com/news-releases/lupin-announces-fda-approval-of-supplemental-new-drug-application-for-solosec-secnidazole-for-the-treatment-of-trichomoniasis-301324270.html
https://www.prnewswire.com/news-releases/lupin-announces-partnership-with-phil-inc-in-support-of-solosec-secnidazole-301218874.html
https://www.biospace.com/article/releases/lupin-announces-fda-filing-acceptance-of-supplemental-new-drug-application-for-solosec-secnidazole-for-the-treatment-of-trichomoniasis/
https://www.prnewswire.com/news-releases/lupin-presents-phase-3-data-for-solosec-secnidazole-demonstrating-significant-response-rate-in-female-patients-with-trichomoniasis-301112461.html
https://www.prnewswire.com/news-releases/lupin-signs-marketing-agreement-with-ceek-for-womens-health-products-to-improve-obgyn-and-patient-exam-experience-301072758.html
https://www.prnewswire.com/news-releases/lupin-announces-solosec-secnidazole-achievement-of-preferred-status-on-express-scripts-national-preferred-formulary-one-of-the-largest-commercial-formularies-in-the-us-301045176.html
http://www.prnewswire.com/news-releases/symbiomix-therapeutics-announces-fdas-acceptance-of-new-drug-application-for-solosec-with-priority-review-status-300427696.html
http://www.drug-dev.com/Main/Current-News/Symbiomix-Submits-New-Drug-Application-to-US-FDA-1808.aspx
http://www.prnewswire.com/news-releases/symbiomix-therapeutics-announces-positive-results-from-phase-3-trial-of-sym-1219-for-bacterial-vaginosis-and-pre-nda-meeting-with-fda-supportive-of-2016-nda-filing-300275353.html
http://portal.anvisa.gov.br/wps/content/anvisa+portal/anvisa/sala+de+imprensa/menu+-+noticias+anos/2015/suspensos+lotes+de+medicamentos+da+empresa+prati+donaduzzi
Market Place
Share 
